Stryker Corporation $SYK Shares Acquired by Aspen Investment Management Inc

Aspen Investment Management Inc increased its position in Stryker Corporation (NYSE:SYK) by 30.7% during the fourth quarter, HoldingsChannel.com reports. The fund owned 6,823 shares of the medical technology company’s stock after acquiring an additional 1,603 shares during the quarter. Aspen Investment Management Inc’s holdings in Stryker were worth $2,398,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Burling Wealth Partners LLC grew its holdings in shares of Stryker by 6.4% in the 4th quarter. Burling Wealth Partners LLC now owns 12,499 shares of the medical technology company’s stock worth $4,393,000 after acquiring an additional 756 shares during the period. Leonteq Securities AG acquired a new stake in shares of Stryker in the 4th quarter worth approximately $489,000. ABN Amro Investment Solutions grew its holdings in shares of Stryker by 41.4% in the 4th quarter. ABN Amro Investment Solutions now owns 200,180 shares of the medical technology company’s stock worth $70,357,000 after acquiring an additional 58,564 shares during the period. Rathbones Group PLC grew its holdings in shares of Stryker by 647.9% in the 4th quarter. Rathbones Group PLC now owns 219,265 shares of the medical technology company’s stock worth $77,065,000 after acquiring an additional 189,948 shares during the period. Finally, IFP Advisors Inc grew its holdings in shares of Stryker by 24.0% in the 4th quarter. IFP Advisors Inc now owns 3,022 shares of the medical technology company’s stock worth $1,062,000 after acquiring an additional 585 shares during the period. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Transactions at Stryker

In related news, VP M Kathryn Fink sold 3,500 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $283.45, for a total value of $992,075.00. Following the completion of the sale, the vice president directly owned 177 shares in the company, valued at approximately $50,170.65. This represents a 95.19% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 4.60% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Piper Sandler restated an “overweight” rating on shares of Stryker in a report on Tuesday, January 27th. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Stryker in a report on Friday, May 1st. Weiss Ratings cut Stryker from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, May 4th. BTIG Research lowered their target price on Stryker from $397.00 to $379.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Finally, The Goldman Sachs Group reiterated a “neutral” rating and set a $361.00 target price on shares of Stryker in a report on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $395.48.

Stryker Trading Up 1.0%

Shares of Stryker stock opened at $320.99 on Thursday. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $404.87. The firm has a market cap of $123.06 billion, a PE ratio of 37.15, a P/E/G ratio of 2.00 and a beta of 0.80. The business’s fifty day moving average is $326.71 and its two-hundred day moving average is $350.36. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The business had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period in the prior year, the company earned $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Analysts anticipate that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a $0.88 dividend. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s dividend payout ratio (DPR) is 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.